Ukr.Biochem.J. 2022; Volume 94, Issue 3, May-Jun, pp. 53-58

doi: https://doi.org/10.15407/ubj94.03.053

Dynamics of homocysteine level in patients with osteoporotic fracture

29.09.2022   Uncategorized   No comments

N. A. Hasanova

Azerbaijan Medical University, Biochemical Department, Baku, Azerbaijan;
e-mail: hasanovanaila@yahoo.com

Received: 04 June 2022; Revised: 01 August 2022;
Accepted: 29 September 2022; Available on-line: 06 October 2022

The research was carried out in order to investigate the blood serum level of homocysteine (HCY) which is involved in bone metabolism and has prognostic significance in the monitoring of the regenerative processes in osteoporosis and osteoporotic fractures. The study was carried out on patients 45-83 years old divided into 3 groups: group I – 14 patients with osteoporosis confirmed by densitometry or X-ray examination­, group II – 15 patients with non-osteoporosis fractures, group III – 25 patients with osteoporotic fractures. The control group consisted of practically healthy 14 people. In patients with various fractures osteosynthesis with Ilizarov apparatus or with metal plates was performed. After the operation, the patients were treated in an inpatient setting for a week, then sent for outpatient treatment and prescribed calcium and vitamin D supplements to accelerate the bone regeneration process. A blood sample was taken at 3 stages to monitor the dynamics of HCY level by Elisa test: on the 1st day before treatment, on the 10th day of treatment and 1 month after it. The results showed that on the 1st day before the treatment HCY concentration was statistically increased 2.7 times in group I, 5.6 times in group II, and 6.5 times in group III compared to the control group. In the month of recovery, a significant decrease in HCY level was observed in all treated groups but it still remained higher than in the control indicating the need to recommend additional therapeutic prescriptions.

Keywords: , ,

References:

  1. Kanis JA, Cooper C, Rizzoli R, Reginster JY. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int. 2019;30(1):3-44. PubMed, PubMedCentral, CrossRef
  2. Saito M, Marumo K. The Effects of Homocysteine on the Skeleton. Curr Osteoporos Rep. 2018;16(5):554-560. PubMed, CrossRef
  3. Périer MA, Gineyts E, Munoz F, Sornay-Rendu E, Delmas PD. Homocysteine and fracture risk in postmenopausal women: the OFELY study. Osteoporos Int. 2007;18(10):1329-1336. PubMed, CrossRef
  4. Herrmann M, Kraenzlin M, Pape G, Sand HM, Herrmann W. Relation between homocysteine and biochemical bone turnover markers and bone mineral density in peri- and postmenopausal women. Clin Chem Lab Med. 2005;43(10): 1118-1123. CrossRef
  5. Weber DR, Coughlin C, Brodsky JL, Lindstrom K, Ficicioglu C, Kaplan P, Freehauf CL, Levine MA. Low bone mineral density is a common finding in patients with homocystinuria. Mol Genet Metab. 2016;117(3):351-354. PubMed, PubMedCentral, CrossRef
  6. Leboff MS, Narweker R, LaCroix A, Wu L, Jackson R, Lee J, Bauer DC, Cauley J, Kooperberg C, Lewis C, Thomas AM, Cummings S. Homocysteine levels and risk of hip fracture in postmenopausal women. J Clin Endocrinol Metab. 2009;94(4):1207-1213. PubMed, PubMedCentral, CrossRef
  7. Narvaez J, Maldonado G, Intriago M, Cardenas J, Guerrero R, Neyro JL, Rios C. Role of homocysteine and vitamin B in bonу metabolism. Rev Colomb Reumatol. 2020;27(4):278-285. CrossRef
  8. Selhub J. Public health significance of elevated homocysteine. Food Nutr Bull. 2008;29(2 Suppl):S116-S125. PubMed, CrossRef
  9. Vacek TP, Kalani A, Voor MJ, Tyagi SC, Tyagi N. The role of homocysteine in bone remodeling. Clin Chem Lab Med. 2013;51(3):579-590. PubMed, PubMedCentral, CrossRef
  10. Behera J, Bala J, Nuru M, Tyagi SC, Tyagi N. Homocysteine as a Pathological Biomarker for Bone Disease. J Cell Physiol. 2017;232(10):2704-2709. PubMed, PubMedCentral, CrossRef
  11. Kim JI, Moon JH, Chung HW, Kong MH, Kim HJ. Association between homocysteine and bone mineral density according to age andsex in healthy adults. J Bone Metab. 2016;23(3):129-134. PubMed, PubMedCentral, CrossRef
  12. Van Meurs JB, Dhonukshe-Rutten RAM, Pluijm SMF, van der Klift M, de Jonge R, Lindemans J, de Groot LC, Hofman A, Witteman JCM, van Leeuwen JP, Breteler MMB, Lips P, Pols HAP, Uitterlinden AG. Homocysteine levels and the risk of osteoporotic fracture. N Engl J Med. 2004;350(20):2033-2041. PubMed, CrossRef
  13. Van Meurs JB, Uitterlinden AG. Homocysteine and fracture prevention. JAMA. 2005;293(9):1121-1122. PubMed, CrossRef
  14. McLean RR, Jacques PF, Selhub J, Tucker KL, Samelson EJ, Broe KE, Hannan MT, Cupples LA, Kiel DP. Homocysteine as a predictive factor for hip fracture in older persons. N Engl J Med. 2004;350(20):2042-2049. PubMed, CrossRef
  15. Périer MA, Gineyts E, Munoz F, Sornay-Rendu E, Delmas PD. Homocysteine and fracture risk in postmenopausal women: the OFELY study. Osteoporos Int. 2007;18(10):1329-1336. PubMed, CrossRef
  16. Dhonukshe-Rutten RA, Pluijm SM, de Groot LC, Lips P, Smit JH, van Staveren WA. Homocysteine and vitamin B12 status relate to bone turnover markers, broadband ultrasound attenuation, and fractures in healthy elderly people. J Bone Miner Res. 2005;20(6):921-929. PubMed, CrossRef
  17. Pooneh Salari P, Larijani B, Abdollahi M. Association hyperhomocysteinemia with osteoporosis: a systematic review. Therapy. 2008;5(2):215-222. CrossRef
  18. Lim JS, Lee DH. Changes in bone mineral density and body composition of children with well-controlled homocystinuria caused by CBS deficiency. Osteoporos Int. 2013;24(9):2535-2538. PubMed, CrossRef
  19. Wang P, Liu L, Lei SF. Causal effects of homocysteine levels on the changes of bone mineral density and risk for bone fracture: A two-sample mendelian randomization study. Clin Nutr. 2021;40(4):1588-1595. PubMed, CrossRef
  20. Yang J, Hu X, Zhang Q, Cao H, Wang J, Liu B. Homocysteine level and risk of fracture: A meta-analysis and systematic review. Bone. 2012;51(3):376-382. PubMed, CrossRef
  21. Enneman AW, Swart KM, Zillikens MC, van Dijk SC, van Wijngaarden JP, Brouwer-Brolsma EM, Dhonukshe-Rutten RA, Hofman A, Rivadeneira F, van der Cammen TJ, Lips P, de Groot CP, Uitterlinden AG, van Meurs JB, van Schoor NM, van der Velde N. The association between plasma homocysteine levels and bone quality and bone mineral density parameters in older persons. Bone. 2014;63:141-146. PubMed, CrossRef
Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License.